Clinical Trial Update: Clinical Outcomes of C3 Glomerulopathy and IC-MPGN in Russia: Hybrid Retrospective - Prospective Study

View source ↗

Summary

Clinical trial update describing a hybrid retrospective-prospective study of outcomes in C3 glomerulopathy and immune complex-mediated membranoproliferative glo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• C3 Glomerulopathy
• Immune Complex-mediated Membranoproliferative Glomerulonephritis

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Diseases | Status: NOT_YET_RECRUITING